http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005051349-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_755f0e063405a160b3444126780baba9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0ead14c2d0648d91b85acd07b66153d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab7c3a9b57d0d5fabafab72842f4eea9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_693afba7854f1677f9b5c1e778c275e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8143e171145e97dada935cd54cb0d583
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2004-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54a1837a35c9bf8c6cbe225094fdd0d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83177d174dde02e4938eb9a7f03fce20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_000b6dc862234110c02ac207c609c425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54d0a5b7534c42cb3575ed25f52ab5fd
publicationDate 2005-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005051349-A3
titleOfInvention Pharmaceutical compositions of mirtazapine
abstract The present invention relates to pharmaceutical compositions of mirtazapine or its pharmaceutically acceptable salts. More particularly, the present invention relates to solid unit dosage forms of anhydrous mirtazapine or its pharmaceutically acceptable salts suitable for oral administration. The present invention also relates to a process for the preparation of pharmaceutical compositions of mirtazapine or its pharmaceutically acceptable salts.
priorityDate 2003-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0436252-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0126621-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1225174-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0158453-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1209159-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421655

Total number of triples: 31.